Showing results (21-30 of 1,348) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|April 29, 2016
A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult SubjectsCraig R Shadle, M Gail Murphy, Yang Liu, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Pharmacokinetics and Bioequivalence Evaluation of 2 Cefadroxil Suspensions in Healthy Egyptian Male VolunteersNoha O MansourClinical Pharmacology in Drug Development|April 29, 2016
Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy VolunteersPeter Dogterom, Cees Timmer, Rik de Greef, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast CancerManish Gupta, Bei Wang, Timothy J Carrothers, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination GelTerry M Jones, Stacy Jasper, Alessandra B Alió SáenzClinical Pharmacology in Drug Development|April 29, 2016
A Randomized Phase I Evaluation of CTP-499, a Novel Deuterium-Containing Drug Candidate for Diabetic NephropathyVirginia Braman, Philip Graham, Changfu Cheng, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly AdultsWei Liu, David A Katz, Charles Locke, et al.Clinical Pharmacology in Drug Development|April 29, 2016
A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With HypertensionHoward Lee, In-Jin Jang, Kyung-Sang Yu, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Pharmacokinetics and Bioequivalence Evaluation of 2 Loxoprofen Tablets in Healthy Egyptian Male VolunteersSally A HelmyClinical Pharmacology in Drug Development|April 29, 2016
Pitavastatin Concentrations Are Not Increased by CYP3A4 Inhibitor Itraconazole in Healthy SubjectsShunji Nakagawa, Masahiko Gosho, Yuji Inazu, et al.Pageof 135